» Articles » PMID: 35565811

Serum, Dietary, and Supplemental Vitamin D Levels and Insulin Resistance in 6294 Randomly Selected, Non-Diabetic U.S. Adults

Overview
Journal Nutrients
Date 2022 May 14
PMID 35565811
Authors
Affiliations
Soon will be listed here.
Abstract

The primary aim of this study was to determine the associations between serum, dietary, and supplemental vitamin D levels and insulin resistance in 6294 non-diabetic U.S. adults. A total of 8 years of data from the 2011−2018 National Health and Nutrition Examination Survey (NHANES) and a cross-sectional design were utilized to answer the research questions. Serum vitamin D levels were quantified using high-performance liquid chromatography−tandem mass spectrometry. Dietary and supplemental vitamin D intakes were assessed using the average of two 24 h dietary recalls taken 3−10 days apart. The homeostatic model assessment (HOMA), based on fasting glucose and fasting insulin levels, was employed to index insulin resistance. Demographic covariates were age, sex, race, and year of assessment. Differences in physical activity, body mass index (BMI), cigarette smoking, body weight, season, and energy intake were also controlled statistically. Serum levels of vitamin D differed significantly, and in a dose−response order, across quartiles of HOMA-IR, after adjusting for year, age, sex, and race (F = 30.3, p < 0.0001) and with all the covariates controlled (F = 5.4, p = 0.0029). Dietary vitamin D levels differed similarly across HOMA-IR quartiles, but to a lesser extent, respectively (F = 8.1, p = 0.0001; F = 2.9, p = 0.0437). Likewise, supplemental vitamin D levels also differed across the HOMA-IR quartiles, respectively (F = 3.5, p = 0.0205; F = 3.3, p = 0.0272). With all the covariates controlled, the odds of having insulin resistance were significantly greater for those in the lowest quartile of serum and supplemental vitamin D intake compared to the other quartiles combined. In conclusion, in this nationally representative sample, serum, dietary, and supplemental vitamin D were each predictive of insulin resistance, especially in those with low serum levels and those with no supplemental intake of vitamin D.

Citing Articles

Environmental Temperature, Other Climatic Variables, and Cardiometabolic Profile in Acute Myocardial Infarction.

Vassalle C, Grifoni D, Gozzini B, Parlanti A, Fibbi L, Marchi F J Clin Med. 2024; 13(7).

PMID: 38610863 PMC: 11012411. DOI: 10.3390/jcm13072098.


A Comparison Study of Nutritional Assessment, Diet and Physical Activity Habits, Lifestyle and Socio-Demographic Characteristics in Individuals with and without Dizziness/Vertigo.

Gunes-Bayir A, Tandogan Z, Gedik-Toker O, Yabaci-Tak A, Dadak A Nutrients. 2023; 15(18).

PMID: 37764839 PMC: 10534566. DOI: 10.3390/nu15184055.


The Effect of Vitamin D Supplementation on the Severity of Symptoms and the Quality of Life in Irritable Bowel Syndrome Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Abuelazm M, Muhammad S, Gamal M, Labieb F, Amin M, Abdelazeem B Nutrients. 2022; 14(13).

PMID: 35807798 PMC: 9268238. DOI: 10.3390/nu14132618.

References
1.
Chen X, Chu C, Doebis C, von Baehr V, Hocher B . Sex-Dependent Association of Vitamin D With Insulin Resistance in Humans. J Clin Endocrinol Metab. 2021; 106(9):e3739-e3747. DOI: 10.1210/clinem/dgab213. View

2.
Al-Daghri N, Al-Attas O, Alokail M, Alkharfy K, Al-Othman A, Draz H . Hypovitaminosis D associations with adverse metabolic parameters are accentuated in patients with Type 2 diabetes mellitus: a body mass index-independent role of adiponectin?. J Endocrinol Invest. 2011; 36(1):1-6. DOI: 10.3275/8183. View

3.
Ebron K, Andersen C, Aguilar D, Blesso C, Barona J, Dugan C . A Larger Body Mass Index is Associated with Increased Atherogenic Dyslipidemia, Insulin Resistance, and Low-Grade Inflammation in Individuals with Metabolic Syndrome. Metab Syndr Relat Disord. 2015; 13(10):458-64. DOI: 10.1089/met.2015.0053. View

4.
Harris S, Pittas A, Palermo N . A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans. Diabetes Obes Metab. 2012; 14(9):789-94. DOI: 10.1111/j.1463-1326.2012.01605.x. View

5.
Lemieux P, Weisnagel S, Caron A, Julien A, Morisset A, Carreau A . Effects of 6-month vitamin D supplementation on insulin sensitivity and secretion: a randomised, placebo-controlled trial. Eur J Endocrinol. 2019; 181(3):287-299. DOI: 10.1530/EJE-19-0156. View